Clinical Trial Update: Atomoxetine for ATS and Opioid Dependence During Buprenorphine Maintenance Treatment in Malaysia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating atomoxetine as an add-on therapy for co-occurring stimulant use disorder and opioid use disorder in individuals on buprenorphine main…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Stimulant Use Disorder

Drugs mentioned

• STRATTERA (Atomoxetine hydrochloride)

Snippet

Sponsor: Yale University | Conditions: Opiate Dependence, Stimulant Dependence | Phase 2 | Status: COMPLETED